Last week Rick had his three-month scan extravaganza. It seems like years (it has only been 20 months) since I wheeled a very sick husband through MDA’s automatic doors. It is probably why before backing out of the driveway, I asked Rick if he still remembered his patient number. The seven-digit number is asked multiple times by MDA personnel before testing. Yep, like our social security numbers, these digits are forever embeded in both our brains.
Rick just completed six months of observation without any medication. Previously, he had a couple of different types chemo pills which were a disaster. And before that months of immunotherapy. Testing and results this time around were going to be a very big deal.
So on Friday there was a bone scan, bloodwork (I lovingly call “bloodletting”), CT and a mega-MRI scans. I highly recommend having scans on Friday. Everything went so smoothly, in about 6 a.m. and out by 4 p.m. That was probably the shortest scan day in our history. We were both pinching ourselves. We even had time to catch a quick bite to eat at the Rotary House’s restaurant between the CT and MRI scan.
And today we received Rick’s stunning scan results from our favorite oncologist, Dr. Campbell. All the scans are the same as three months ago … stable. His lipase was even normal. Thank you Jesus and MD Anderson. We talked a lot about the trial he had been on. The reflection was good for our soul. This immunotherapy stuff has only been around seriously since 2012. I think it all started with treating Melonoma patients. Rick started on his Immunotherapy Trial for Clear Cell Kidney Cancer in early 2016. Since then, his trial has expanded from 60 patients to 105. That is because patients were doing so well. Rick’s combination of two drugs have a 58% positive response rate. The one drug has a 42% positive response rate. Dr. Campbell indicated they will have all their slots full on the trial by the end of the year for the 105 patients. These positive results bode well for future Clear Cell Kidney Cancer patients.
Dr. Campbell told us that they are expanding the types of cancers that receive immunotherapy ALL THE TIME. There are also new drugs being developed ALL THE TIME. He also said they have learned that some of the old drugs may not hold cancer at bay forever. Some of the drugs are doing very well. The good news is that patients, like Rick, who respond well to immunotherapy have a great chance that if cancer does return there will be lots more new treatment options to chose from.
We go back for scans in three months. If that visit is stable … four month scans.